Boyd Biomedical Selected as Member of ARPA-H Investor Catalyst Hub

Lee, Massachusetts - Boyd Biomedical announced today that it was selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health innovation network launched by the Advanced Research Projects Agency for Health (ARPA-H).

Based in the Greater Boston area and managed by VentureWell, the Investor Catalyst Hub seeks to accelerate the commercialization of groundbreaking and accessible biomedical solutions. It utilizes an innovative hub-and-spoke model designed to reach a wide range of nonprofit organizations and Minority-Serving Institutions, with the ultimate aim of delivering scalable healthcare outcomes for all Americans.

 

“We’re thrilled to be selected as a spoke of the ARPA-H Investor Catalyst Hub. This is a nationwide network dedicated to accelerating groundbreaking advances in science and medicine which is aligned with our mission to provide the industry-leading growth platform to biomedical companies commercializing breakthrough innovations.”

STEPHEN BOYD
Chief Executive Officer, Boyd Biomedical

 

Boyd Biomedical joins a dynamic nationwide network of organizations aligned to ARPA-H’s overarching mission to improve health outcomes through the following research focus areas: health science futures, proactive health, scalable solutions, and resilient systems. Investor Catalyst Hub spokes represent a broad spectrum of expertise, geographic diversity, and community perspectives. 

“Our spoke network embodies a rich and representative range of perspectives and expertise,” said Mark Marino, Vice President of Growth Strategy and Development for VentureWell and Project Director for the Investor Catalyst Hub. “Our spokes comprise a diverse network that will be instrumental in ensuring that equitable health solutions reach communities across every state and tribal nation.”

As an Investor Catalyst Hub spoke, Boyd Biomedical gains access to potential funding and flexible contracting for faster award execution compared to traditional government contracts. Spoke membership also offers opportunities to provide input on ARPA-H challenge areas and priorities, along with access to valuable networking opportunities and a robust resource library.


About Boyd Biomedical

Boyd Biomedical is a growth partner for medical device and life sciences companies. Our growth platform provides a full suite of services to design, build, and launch regulated devices and liquid media solutions. We deliver innovation best to market.

The Company is ISO 13485 certified, and FDA registered as a contract design and manufacturing organization for medical devices. The Company has two locations: headquarters and manufacturing in Lee, Massachusetts, and a sales office in Boston, Massachusetts. The Company was founded in 1979 and is privately held. For more information about Boyd Biomedical, visit www.boydbiomedical.com.